Fifty-five organic and aqueous extracts of 11 plants used in malaria therapy in Kisii District, Kenya were tested in vitro against chloroquine (CQ)-sensitive and resistant strains of Plasmodium falciparum. Of the plants tested, 73% were active (IC(50) < 100 microg/ml). Three plants, Vernonia lasiopus, Rhamnus prinoides and Ficus sur afforded extracts with IC(50) values ranging less than 30 microg/ml against both CQ-sensitive and resistant strains. Combination of some extracts with CQ against the multi-drug resistant P. falciparum isolate V1/S revealed some synergistic effect. The plant extracts with low IC(50) values may be used as sources for novel antimalarial compounds to be used alone or in combination with CQ.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0378-8741(02)00327-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Towards Novel Antiplasmodial Agents-Design, Synthesis and Antimalarial Activity of Second-Generation β-Carboline/Chloroquine Hybrids.
Molecules
December 2024
Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, Croatia.
As the resistance of to the existing antimalarials increases, there is a crucial need to expand the antimalarial drug pipeline. We recently identified potent antimalarial compounds, namely harmiquins, hybrids derived from the β-carboline alkaloid harmine and 4-amino-7-chloroquinoline, a key structural motif of chloroquine (CQ). To further explore the structure-activity relationship, we synthesised 13 novel hybrid compounds at the position -9 of the β-carboline ring and evaluated their efficacy in vitro against 3D7 and Dd2 strains (CQ sensitive and multi-drug resistant, respectively).
View Article and Find Full Text PDFDesign and synthesis of pyrano[2,3-c]pyrazole-4-aminoquinoline hybrids as effective antimalarial compounds.
Eur J Med Chem
December 2024
Department of Chemical Sciences, Faculty of Science and Technology, Universiti Kebangsaan Malaysia (UKM), Bangi, 43600, Selangor, Malaysia. Electronic address:
In this work, a series of nineteen novel pyrano[2,3-c]pyrazole-4-aminoquinoline hybrids were synthesized as potent antimalarial agents by covalently linking the scaffolds of 4-aminoquinoline and pyrano[2,3-c]pyrazoles via an ethyl linker and characterized using Fourier transform infrared spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (NMR). Molecular docking was used to test each hybrid's and standard chloroquine's ability to bind to Plasmodium falciparum lactate dehydrogenase enzyme (PfLDH), an important enzyme in the parasite's glycolytic pathway. The hybrid compounds had a stronger binding affinity than the standard chloroquine (CQ).
View Article and Find Full Text PDFSulfonamide based pyrimidine derivatives combating parasite by inhibiting falcipains-2 and falcipains-3 as antimalarial agents.
RSC Adv
August 2024
Drug Design and Synthesis Lab., Department of Chemistry Jamia Millia Islamia, Jamia Nagar New Delhi 110025 India +0091-11-26985507 +0091-9910200655.
In this report, we present the design and synthesis of a novel series of pyrimidine-tethered spirochromane-based sulfonamide derivatives aimed at combating drug resistance in malaria. The antimalarial effectiveness of these compounds was assessed . Structural validation of the synthesized compounds was conducted using mass spectrometry and NMR spectroscopy.
View Article and Find Full Text PDFPreliminary insight on diarylpentanoids as potential antimalarials: In silico, in vitro LDH and in vivo zebrafish toxicity assessment.
Heliyon
March 2024
Department of Biology, Chungnam National University, Daejeon, 34134, South Korea.
Malaria remains a major public health problem worldwide, including in Southeast Asia. Chemotherapeutic agents such as chloroquine (CQ) are effective, but problems with drug resistance and toxicity have necessitated a continuous search for new effective antimalarial agents. Here we report on a virtual screening of ∼300 diarylpentanoids and derivatives, in search of potential lactate dehydrogenase (LDH) inhibitors with acceptable drug-like properties.
View Article and Find Full Text PDFEfficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins.
Front Pharmacol
January 2024
Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
Article Synopsis
- Researchers are exploring new artemisinin triple combination therapies to combat artemisinin-tolerant strains using combinations of artemisone or other amino-artemisinins, a redox-active drug, and a third drug with a different action.
- Three potential redox partners have been evaluated: AD01, PhX6, and DpNEt, with PhX6 showing the most promising pharmacokinetic profile and efficacy against CQ-sensitive and resistant strains.
- Future studies will expand drug combinations to include artemiside and test the effectiveness of artemisone with PhX6 and the related compound SSJ-183.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!